Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial
- PMID: 12833014
- DOI: 10.1067/mjd.2003.451
Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial
Abstract
Background: Adapalene is a synthetic retinoid with an established clinical efficacy against acne and good local tolerability. Its effectiveness in the treatment of photodamaged skin has not been studied.
Objective: We sought to determine the safety and efficacy of adapalene gel in the treatment of actinic keratoses and solar lentigines.
Methods: In a prospective, 2-center, randomized, controlled, investigator-masked, parallel-group study, 90 patients with actinic keratoses and solar lentigines were treated daily with either adapalene gel (0.1% or 0.3%) or its vehicle gel for 4 weeks, followed by twice-daily applications, if tolerated, for up to 9 months.
Results: Of the 90 Caucasian patients (69 male, 21 female; mean age 63.1 years) who were enrolled into the study, 83 patients completed 9 months of treatment. With adapalene gel 0.1% and 0.3%, the mean number of actinic keratoses was reduced by 0.5 +/- 0.9 (mean +/- SE) and 2.5 +/- 0.9, respectively. Whereas, with the vehicle gel, there was an increase of 1.5 +/- 1.3 (P <.05). After 1 month of treatment, the patients who received adapalene had significant lightening of solar lentigines as compared with the patients who were treated with vehicle gel (P <.05). After 9 months, 57% and 59% of the patients had lighter lesions in the adapalene 0.1% and 0.3% groups, respectively, in comparison with only 36% in the vehicle group (P <.05). Histologic evaluations revealed improved cellular atypia and reduced epidermal melanin in adapalene-, as compared with vehicle-treated group. The differences, however, were not statistically significant. A retrospective evaluation of paired clinical photographs (before and after 9-month treatment) by 2 dermatologists who were treatment-blinded revealed significant improvement in wrinkles and other clinical features of photoaged skin with adapalene as compared with its vehicle.
Conclusion: Adapalene gel 0.1% and 0.3% were well tolerated and improved actinic keratoses, solar lentigines, and other features of photodamaged skin.
Similar articles
-
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.Arch Dermatol. 2006 May;142(5):597-602. doi: 10.1001/archderm.142.5.597. Arch Dermatol. 2006. PMID: 16702497 Clinical Trial.
-
Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.Br J Dermatol. 2004 Aug;151(2):481-4. doi: 10.1111/j.1365-2133.2004.06067.x. Br J Dermatol. 2004. PMID: 15327558 Clinical Trial.
-
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.Cutis. 2005 Aug;76(2):145-51. Cutis. 2005. PMID: 16209161 Clinical Trial.
-
Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.Am J Clin Dermatol. 2003;4(3):203-13. doi: 10.2165/00128071-200304030-00007. Am J Clin Dermatol. 2003. PMID: 12627996 Review.
-
Effective treatment of localized Darier's disease with adapalene 0.1% gel.Cutis. 1999 Apr;63(4):227-30. Cutis. 1999. PMID: 10228752 Review.
Cited by
-
Application of ultrasound-mediated adapalene-coated lysozyme-shelled microbubbles in UVA-induced skin photoaging.PLoS One. 2020 May 21;15(5):e0232617. doi: 10.1371/journal.pone.0232617. eCollection 2020. PLoS One. 2020. PMID: 32438389 Free PMC article.
-
Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations.Adv Ther. 2022 Dec;39(12):5351-5375. doi: 10.1007/s12325-022-02319-7. Epub 2022 Oct 11. Adv Ther. 2022. PMID: 36220974 Free PMC article. Review.
-
Interventions for actinic keratoses.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235610 Free PMC article.
-
Blue Laser (450 nm) Treatment of Solar Lentigines.J Clin Med. 2021 Oct 24;10(21):4919. doi: 10.3390/jcm10214919. J Clin Med. 2021. PMID: 34768439 Free PMC article.
-
[Skin tumours of the facial area].HNO. 2009 Apr;57(4):302-14. doi: 10.1007/s00106-009-1891-6. HNO. 2009. PMID: 19322550 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources